Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
SynKinase
PFI-4
71
CHF
CHF 71.00
In stock
SYN-3047-M0011 mgCHF 71.00
SYN-3047-M0055 mgCHF 99.00
SYN-3047-M01010 mgCHF 128.00
SYN-3047-M05050 mgCHF 454.00
SYN-3047-M100100 mgCHF 837.00
| Product Details | |
|---|---|
| Synonyms | N-[2,3-Dihydro-1,3-dimethyl-2-oxo-6-(1-pyrrolidinyl)-1H-benzimidazol-5-yl]-2-methoxy benzamide |
| Product Type | Chemical |
| Properties | |
| Formula | C21H24N4O3 |
| MW | 380.5 |
| CAS | 900305-37-5 |
| Purity Chemicals | ≥95% |
| Appearance | Solid. |
| Solubility | Soluble in DMSO. |
| Declaration | Manufactured by SynKinase. |
| Other Product Data | Target: BRPF1 | Kinase Group: N/A | Substrate: N/A |
| InChi Key | QCIJLRJBZDBVDB-UHFFFAOYSA-N |
| Shipping and Handling | |
| Shipping | AMBIENT |
| Short Term Storage | +4°C |
| Long Term Storage | -20°C |
| Use/Stability | Stable for at least 2 years after receipt when stored at -20°C. |
| Documents | |
| MSDS | Inquire |
| Product Specification Sheet | |
| Datasheet |
 Download PDF |
Description
Potent and selective BRPF1 bromodomain inhibitor, with an IC50 of 80nM. PFI-4 exhibits >100-fold selectivity for BRPF1 over a panel of other bromodomains including BRPF2 (BRD1), BRPF3 and BRD4. PFI-4 specifically binds to the bromodomain of BRPF1 (Kd = 13nM), inhibiting binding to tri-acetylated histone 4 (residues 1-21). PFI-4 is potent in cells, with an IC50 value of 250nM.
Product References
- 1,3-Dimethyl Benzimidazolones Are Potent, Selective Inhibitors of the BRPF1 Bromodomain: E.H. Demont, et al.; ACS Med. Chem. Lett. 5, 1190 (2014)
Related Products
